Wolverine Asset Management LLC Blueprint Medicines Corp Transaction History

Wolverine Asset Management LLC

  • $4.35 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$80.98 - $109.47 $117,825 - $159,278
-1,455 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$82.78 - $101.0 $120,444 - $146,955
1,455 New
1,455 $127,000
Q3 2020

Nov 13, 2020
SELL
$66.45 - $92.7 $730 - $1,019
-11 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$57.09 - $79.27 $627 - $871
11 New
11 $0

Others Institutions Holding BPMC

# of Institutions
350
Shares Held
60.3M
Call Options Held
2.25M
Put Options Held
1.18M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.3B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email